Interactive role of diastolic dysfunction and ventricular remodeling in asymptomatic subjects at increased risk of heart failure.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 28 11 2018
accepted: 11 02 2019
pubmed: 1 3 2019
medline: 23 7 2019
entrez: 1 3 2019
Statut: ppublish

Résumé

Diastolic dysfunction (DD) and left ventricular remodeling (LVR) characterize patients at risk for heart failure (HF). To assess the prognostic impact of different diastolic function algorithms and a complex LVR classification (CRC) in asymptomatic subjects with preserved ejection fraction (EF) at risk for HF. We analyzed 1923 asymptomatic patients (male 43%; age 57, 33-76 years) with at least one cardiovascular risk factor and preserved (> 50%) EF. We used three algorithms for LV diastolic function assessment (Paulus et al. in Eur Heart J 28(20):2539-2550, 2007; Nagueh et al. in J Am Soc Echocardiogr 22(2):107-133, 2009, Eur Heart J Cardiovasc Imaging 17(12):1321-1360, 2016), and two algorithms for LVR (classic and CRC). We considered a composite end-point: cardiac death and hospitalization for HF. The highest presence of DD was diagnosed by Nagueh 2009 (211, 11%), while the prevalence according to Nagueh 2016 (63 patients, 3.2%) turned out to be the lowest (p < 0.001 vs the other algorithms). According to CRC, 780 (48.6%) patients had normal or physiologic hypertrophy, 298 (15.5%) concentric remodeling, 85 (4.4%) eccentric remodeling, 294 (15.3%) concentric hypertrophy, 39 (2%) mixed hypertrophy, 80 (4.1%) dilated hypertrophy, 73 (3.7%) eccentric hypertrophy and 294 (15.3%) were unclassifiable. After 39-month follow-up (261 events, 13.6%), Cox-regression (adjusted for age, gender, history of stable ischemic heart disease, classic remodeling classification) identified CRC (p = 0.01) and Nagueh 2016 (p < 0.001) as independent predictors of end-point. The coexistence of an adverse LVR by CRC and DD by Nagueh 2016 was associated with the worst prognosis. A concurrent structural (CRC) and functional (Nagueh Op. Cit) analysis improves prognostic stratification in asymptomatic subjects at risk for HF with preserved EF.

Identifiants

pubmed: 30815808
doi: 10.1007/s10554-019-01560-6
pii: 10.1007/s10554-019-01560-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1231-1240

Références

J Am Coll Cardiol. 2003 Feb 19;41(4):687-708
pubmed: 12598084
Circulation. 2003 Aug 26;108(8):977-82
pubmed: 12912813
Am J Cardiol. 1992 Sep 1;70(6):681-8
pubmed: 1387288
J Cardiovasc Med (Hagerstown). 2006 Jul;7(7):457-63
pubmed: 16801805
J Am Coll Cardiol. 2007 Feb 13;49(6):687-94
pubmed: 17291934
Eur Heart J. 2007 Oct;28(20):2539-50
pubmed: 17428822
Circulation. 2008 May 13;117(19):2544-65
pubmed: 18391114
J Am Soc Echocardiogr. 2009 Feb;22(2):107-33
pubmed: 19187853
J Am Coll Cardiol. 2010 Mar 16;55(11):1057-65
pubmed: 20223363
JACC Cardiovasc Imaging. 2011 Jan;4(1):98-108
pubmed: 21232712
JAMA. 2011 Aug 24;306(8):856-63
pubmed: 21862747
J Am Coll Cardiol. 2011 Oct 18;58(17):1733-40
pubmed: 21996383
Circulation. 2011 Dec 6;124(23):2491-501
pubmed: 22064591
Circ Heart Fail. 2014 Jan;7(1):104-15
pubmed: 24249049
Circ Heart Fail. 2014 Mar 1;7(2):288-99
pubmed: 24365774
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
JACC Heart Fail. 2015 Jun;3(6):445-455
pubmed: 25982111
Eur Heart J Cardiovasc Imaging. 2015 Jun;16(6):577-605
pubmed: 25995329
J Am Coll Cardiol. 2016 Jan 26;67(3):330-7
pubmed: 26796399
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1321-1360
pubmed: 27422899
Am J Cardiol. 2017 Jan 1;119(1):71-77
pubmed: 27776801
Circulation. 2017 Jan 17;135(3):224-240
pubmed: 27881564
Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):961-968
pubmed: 28444160
Am J Epidemiol. 2017 Jun 15;185(12):1221-1227
pubmed: 28453616
J Am Soc Hypertens. 2017 Jul;11(7):412-419
pubmed: 28619598
J Am Coll Cardiol. 2017 Jun 27;69(25):3119-3121
pubmed: 28641802
JACC Heart Fail. 2017 Aug;5(8):543-551
pubmed: 28711447
Echocardiography. 2018 Jan;35(1):39-46
pubmed: 29178212
Eur Heart J. 1993 Nov;14 Suppl J:95-101
pubmed: 8281972

Auteurs

Iacopo Fabiani (I)

Dipartimento di Patologia Medica, Chirurgica, Molecolare e dell'Area Critica, Università di Pisa, Via Paradisa, 2 - Ospedale Cisanello, Pisa, 56100, Italy.

Nicola Riccardo Pugliese (NR)

Dipartimento di Patologia Medica, Chirurgica, Molecolare e dell'Area Critica, Università di Pisa, Via Paradisa, 2 - Ospedale Cisanello, Pisa, 56100, Italy. n.r.pugliese88@gmail.com.

Salvatore La Carrubba (S)

Ospedale Villa Sofia, Palermo, Italy.

Lorenzo Conte (L)

Dipartimento di Patologia Medica, Chirurgica, Molecolare e dell'Area Critica, Università di Pisa, Via Paradisa, 2 - Ospedale Cisanello, Pisa, 56100, Italy.

Paolo Colonna (P)

Azienda Ospedaliero Universitaria Policlinico - Bari U.O.C. Cardiologia Ospedaliera, Bari, Italy.

Pio Caso (P)

Azienda Ospedaliera Monaldi - Napoli, Napoli, Italy.

Frank Benedetto (F)

UOC Cardiologia Clinica e Riabilitativa Azienda Ospedaliera "Bianchi-Melacrino-Morelli" Reggio Calabria, Reggio Calabria, Italy.

Francesco Antonini-Canterin (F)

Ospedale di Pordenone S. Maria degli Angeli-SSD Patologia Cardiovascolare ed Aterosclerosi, Pordenone, Italy.

Rodolfo Citro (R)

AOU "San Giovanni di Dio e Ruggiero d'Aragona" - Salerno, Salerno, Italy.

Frank Lloyd Dini (FL)

Dipartimento di Patologia Medica, Chirurgica, Molecolare e dell'Area Critica, Università di Pisa, Via Paradisa, 2 - Ospedale Cisanello, Pisa, 56100, Italy.

Scipione Carerj (S)

Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Messina, Messina, Italy.

Vitantonio Di Bello (V)

Dipartimento di Patologia Medica, Chirurgica, Molecolare e dell'Area Critica, Università di Pisa, Via Paradisa, 2 - Ospedale Cisanello, Pisa, 56100, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH